The number on your lab report looks precise, official, and final - but without the right context, it can be almost meaningless
A trial of omarigliptin evaluated 4202 diabetic patients without acute ischemic disease, who were followed for a median of 1.8 years, before early termination of the trial [50]
When clinicians think of indications for GLP1-RA use in pediatrics, they primarily think of type 2 diabetes mellitus and obesity and goal for weight loss
Three distinct-type glutathione S-transferases from Escherichia coli important for defense against oxidative stress
Uterine Artery Embolization versus Surgery for Symptomatic Uterine Fibroids: A Randomized Controlled Trial and a Meta-Analysis of the Literature
Serge G, Bianchi E, Corsi M, D'Iddio S, Ghirardi O, Maccari F